Certified by Founder Lodge
Tr1X
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $75,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Tr1X Inc. (pr. "Trix") is a biotechnology company dedicated to the development of novel cellular immunotherapies for patients with autoimmune and inflammatory diseases. The Company uses its
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 19 ,2024 | Series A | $75,000,000 |
Alexandria Real Estate Equities, Inc.
The Column Group
NEVA SGR
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
